Cargando…

Messenger RNA processing is altered in autosomal dominant leukodystrophy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Bartoletti-Stella, Anna, Gasparini, Laura, Giacomini, Caterina, Corrado, Patrizia, Terlizzi, Rossana, Giorgio, Elisa, Magini, Pamela, Seri, Marco, Baruzzi, Agostino, Parchi, Piero, Brusco, Alfredo, Cortelli, Pietro, Capellari, Sabina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886215/ https://www.ncbi.nlm.nih.gov/pubmed/28934398 http://dx.doi.org/10.1093/hmg/ddx225

Ejemplares similares

Messenger RNA processing is altered in autosomal dominant leukodystrophy(†)
por: Bartoletti-Stella, Anna, et al.
Publicado: (2015)

Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts
por: Ferrera, Denise, et al.
Publicado: (2014)

Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes
por: Ratti, Stefano, et al.
Publicado: (2020)

Analysis of LMNB1 Duplications in Autosomal Dominant Leukodystrophy Provides Insights into Duplication Mechanisms and Allele-Specific Expression
por: Giorgio, Elisa, et al.
Publicado: (2013)

Autosomal Dominant Leukodystrophy: A Disease of the Nuclear Lamina
por: Padiath, Quasar S.
Publicado: (2019)

Genomic deletions upstream of lamin B1 lead to atypical autosomal dominant leukodystrophy
por: Nmezi, Bruce, et al.
Publicado: (2019)

Lamin B1 Accumulation’s Effects on Autosomal Dominant Leukodystrophy (ADLD): Induction of Reactivity in the Astrocytes
por: Ratti, Stefano, et al.
Publicado: (2021)

LMNB1‐related autosomal‐dominant leukodystrophy: Clinical and radiological course
por: Finnsson, Johannes, et al.
Publicado: (2015)

Glucose metabolism in the brain in LMNB1‐related autosomal dominant leukodystrophy
por: Finnsson, Johannes, et al.
Publicado: (2018)

Understanding the Ultra-Rare Disease Autosomal Dominant Leukodystrophy: an Updated Review on Morpho-Functional Alterations Found in Experimental Models
por: Neri, Irene, et al.
Publicado: (2023)

Gerstmann-Sträussler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism
por: Baiardi, Simone, et al.
Publicado: (2020)

Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy
por: Mezaki, Naomi, et al.
Publicado: (2018)

Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias
por: Baiardi, Simone, et al.
Publicado: (2018)

LMNB1 Duplication-Mediated Autosomal Dominant Adult-Onset Leukodystrophy in an Indian Family
por: Bijarnia-Mahay, Sunita, et al.
Publicado: (2021)

CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
por: Abu-Rumeileh, Samir, et al.
Publicado: (2019)

The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins
por: Rossi, Marcello, et al.
Publicado: (2019)

Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease
por: Tarozzi, Martina, et al.
Publicado: (2022)

A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD)
por: Giorgio, Elisa, et al.
Publicado: (2015)

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]
Publicado: (2018)

Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients
por: Bonora, Elena, et al.
Publicado: (2014)

Frequency of Parkinson’s Disease Genes and Role of PARK2 in Amyotrophic Lateral Sclerosis: An NGS Study
por: Vacchiano, Veria, et al.
Publicado: (2022)

An in vivo (11)C‐PK PET study of microglia activation in Fatal Familial Insomnia
por: Iaccarino, Leonardo, et al.
Publicado: (2017)

Genomics and epigenomics
por: Garagnani, Paolo, et al.
Publicado: (2015)

Correction to ‘Theoretical basis for stabilizing messenger RNA through secondary structure design’
por: Wayment-Steele, Hannah K, et al.
Publicado: (2021)

Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis
por: Capellari, Sabina, et al.
Publicado: (2018)

An LMNB1 Duplication Caused Adult-Onset Autosomal Dominant Leukodystrophy in Chinese Family: Clinical Manifestations, Neuroradiology and Genetic Diagnosis
por: Dai, Yi, et al.
Publicado: (2017)

LMNB1-Related Adult-Onset Autosomal Dominant Leukodystrophy Presenting as Movement Disorder: A Case Report and Review of the Literature
por: Zhang, Yanyan, et al.
Publicado: (2019)

Corrigendum to “Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease”Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866.
por: Okada, Eri, et al.
Publicado: (2023)

Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias
por: Bentivenga, Giuseppe Mario, et al.
Publicado: (2023)

Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
por: Quadalti, Corinne, et al.
Publicado: (2021)

The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy
por: Becchetti, Andrea, et al.
Publicado: (2015)

Corrigendum: Single-nucleotide polymorphism screening and RNA sequencing of key messenger RNAs associated with neonatal hypoxic-ischemia brain damage
Publicado: (2020)

Diagnostic and prognostic performance of CSF α‐synuclein in prion disease in the context of rapidly progressive dementia
por: Mastrangelo, Andrea, et al.
Publicado: (2021)

The First Sporadic Creutzfeldt–Jakob Disease Case with a Rare Molecular Subtype VV1 and 1-Octapeptide Repeat Deletion in PRNP
por: Areškevičiūtė, Aušrinė, et al.
Publicado: (2021)

Perrone RD, Mouksassi M-S, Romero K, et al. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease. Kidney Int Rep. 2017;2:442–450
Publicado: (2018)

Corrigendum to “Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic” [Adv. Drug Delivery Rev. 179 (2021) 114000]
por: Jain, Samagra, et al.
Publicado: (2022)

Structural basis for the dominant or recessive character of GLIALCAM mutations found in leukodystrophies
por: Elorza-Vidal, Xabier, et al.
Publicado: (2020)

Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings
por: Baiardi, Simone, et al.
Publicado: (2015)

Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ(42) in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer’s Disease with Emphasis on Atypical Disease Variants
por: Abu Rumeileh, Samir, et al.
Publicado: (2016)

Corrigendum to “Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases” [EBioMedicine 54 (2020) 102730]
por: Tan, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2reoas8cirgsjrqlv9mb7plnnj